There was no statistically significant difference between the groups for:
mortality: NHBC/FAP 7.40%, HBC/LAP group 2.40%;
return to operating room for bleeding: NHBC/FAP 2.47%, HBC/LAP 1.60%;
cerebrovascular accident/transient ischemic attack: NHBC 2.40%, HBC/LAP 1.60%;
vascular complications: NHBC 1.20%, HBC/LAP 1.60%;
atrial fibrillation: NHBC 37.0%, HBC/LAP 27.2%; or
renal dysfunction (Cr>2.5): NHBC 6.20%, HBC/LAP 5.60%.
There was a statistically significant difference between the groups for:
perioperative myocardial infarction: NHBC 12.3%, HBC/LAP group 3.20% (95% CI: 0.27, 0.07 - 0.97; p=0.002);
postoperative inotropes: NHBC 38.1%, HBC/LAP 19.2% (95% CI: 0.37, 0.17 - 0.75; p=0.004);
pulmonary complications: NHBC 12.3%, HBC/LAP 4.80% (95% CI: 0.11, 0.01 - 0.85; p=0.05);
myocardial infarction and cerebrovascular accident/transient ischemic attack and vascular complications: NHBC 16.0%, HBC/LAP group 6.40% (95% CI: 0.36, 0.14 - 0.91; p=0.017).
any complication: NHBC group 28.4%, HBC/LAP group 12.8% (95% CI: 0.37, 0.16 - 0.82; p=0.012).